ATE556712T1 - A2a antagonisten zur behandlung von motorischen störungen - Google Patents
A2a antagonisten zur behandlung von motorischen störungenInfo
- Publication number
- ATE556712T1 ATE556712T1 AT10005600T AT10005600T ATE556712T1 AT E556712 T1 ATE556712 T1 AT E556712T1 AT 10005600 T AT10005600 T AT 10005600T AT 10005600 T AT10005600 T AT 10005600T AT E556712 T1 ATE556712 T1 AT E556712T1
- Authority
- AT
- Austria
- Prior art keywords
- antagonists
- treatment
- hydrogen atom
- motor disorders
- substituted
- Prior art date
Links
- 208000019430 Motor disease Diseases 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000002774 3,4-dimethoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C(OC([H])([H])[H])=C1OC([H])([H])[H])C([H])([H])* 0.000 abstract 1
- 102000007471 Adenosine A2A receptor Human genes 0.000 abstract 1
- 108010085277 Adenosine A2A receptor Proteins 0.000 abstract 1
- 208000016285 Movement disease Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000003042 antagnostic effect Effects 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- YWBFPKPWMSWWEA-UHFFFAOYSA-O triazolopyrimidine Chemical class BrC1=CC=CC(C=2N=C3N=CN[N+]3=C(NCC=3C=CN=CC=3)C=2)=C1 YWBFPKPWMSWWEA-UHFFFAOYSA-O 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005166981 | 2005-06-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE556712T1 true ATE556712T1 (de) | 2012-05-15 |
Family
ID=37498474
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT10005600T ATE556712T1 (de) | 2005-06-07 | 2006-06-07 | A2a antagonisten zur behandlung von motorischen störungen |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7851478B2 (de) |
| EP (2) | EP1902716A4 (de) |
| JP (3) | JPWO2006132275A1 (de) |
| AT (1) | ATE556712T1 (de) |
| ES (1) | ES2385702T3 (de) |
| WO (1) | WO2006132275A1 (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7994190B2 (en) | 2006-11-01 | 2011-08-09 | Bristol-Myers Squibb Company | Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
| AU2010207004A1 (en) * | 2009-01-20 | 2011-07-28 | Merck Sharp & Dohme Corp. | Methods of alleviating or treating signs and/or symptoms associated with moderate to severe Parkinson's disease |
| BRPI1009398A2 (pt) | 2009-03-13 | 2016-03-08 | Advinus Therapeutics Private Ltd | compostos de pirimidina fundida substituída |
| TWI548411B (zh) | 2009-04-28 | 2016-09-11 | Kyowa Hakko Kirin Co Ltd | Exercise disorder treatment |
| EP2499142B1 (de) | 2009-11-09 | 2016-09-21 | Advinus Therapeutics Limited | Substituierte kondensierte pyrimidinverbindungen, ihre herstellung und ihre verwendung |
| ES2579949T3 (es) | 2010-02-05 | 2016-08-17 | Heptares Therapeutics Limited | Derivados de 1,2,4-triazin-4-amina |
| WO2012066330A1 (en) | 2010-11-17 | 2012-05-24 | Heptares Therapeutics Limited | Compounds useful as a2a receptor inhibitors |
| JP6308346B2 (ja) * | 2013-05-31 | 2018-04-11 | 三菱自動車工業株式会社 | 車両の制御装置 |
| JP6381883B2 (ja) * | 2013-10-04 | 2018-08-29 | 国立大学法人千葉大学 | 不随意運動の予防及び／又は治療組成物 |
| AU2018389313B2 (en) | 2017-12-19 | 2021-08-19 | Impetis Biosciences Ltd. | Pharmaceutical composition for the treatment of cancer |
| AU2019205661B2 (en) | 2018-01-04 | 2022-06-30 | Impetis Biosciences Ltd. | Tricyclic compounds, compositions and medicinal applications thereof |
| AU2019227607C1 (en) | 2018-02-27 | 2023-07-20 | Incyte Corporation | Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors |
| EP3810610A1 (de) | 2018-05-18 | 2021-04-28 | Incyte Corporation | Kondensierte pyrimidinderivate als a2a/a2b-inhibitoren |
| CN117304191A (zh) | 2018-07-05 | 2023-12-29 | 因赛特公司 | 作为a2a/a2b抑制剂的稠合吡嗪衍生物 |
| TWI829857B (zh) | 2019-01-29 | 2024-01-21 | 美商英塞特公司 | 作為a2a / a2b抑制劑之吡唑并吡啶及三唑并吡啶 |
| JP7299307B2 (ja) * | 2019-04-03 | 2023-06-27 | テラ・ストーン株式会社 | チミン核酸塩基をベースとするトリアゾロピリミジン類及びその製造方法 |
| WO2022029063A1 (en) | 2020-08-04 | 2022-02-10 | Bayer Aktiengesellschaft | Pyrido[1,2,4]triazolo[1,5-c]pyrimidin-5-amines |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4431638B2 (ja) | 1996-01-29 | 2010-03-17 | アメリカ合衆国 | ジヒドロピリジン―、ピリジン―、ベンゾピラン―オン―およびトリアゾロキナゾリン誘導体、それらの製造およびそれらのアデノシン受容体アンタゴニストとしての用途 |
| WO1998042711A1 (en) | 1997-03-24 | 1998-10-01 | Kyowa Hakko Kogyo Co., Ltd. | [1,2,4]TRIAZOLO[1,5-c]PYRIMIDINE DERIVATIVES |
| AU2639299A (en) | 1998-02-24 | 1999-09-15 | Kyowa Hakko Kogyo Co. Ltd. | Remedies/preventives for parkinson's disease |
| KR20010087361A (ko) * | 1998-09-22 | 2001-09-15 | 히라타 다다시 | [1,2,4]트리아졸로[1,5-ｃ]피리미딘 유도체 |
| AR023966A1 (es) | 1999-05-12 | 2002-09-04 | Fujisawa Pharmaceutical Co | Una composicion farmaceutica para la prevencion y/o el tratamiento de la enfermedad de parkinson y los sintomas concomitantes de la misma, y el uso de unantagonista dual receptor de adenosina a1 a2a para preparar dicha composicion |
| US20040152659A1 (en) * | 1999-05-12 | 2004-08-05 | Fujisawa Pharmaceutical Co. Ltd. | Method for the treatment of parkinson's disease comprising administering an A1A2a receptor dual antagonist |
| JP2001302648A (ja) | 2000-04-28 | 2001-10-31 | Kyowa Hakko Kogyo Co Ltd | ピペラジン誘導体の製造法 |
| PT1283839E (pt) | 2000-05-26 | 2005-08-31 | Schering Corp | Antagonistas do receptor a2a da adenosina |
| GB0100624D0 (en) * | 2001-01-10 | 2001-02-21 | Vernalis Res Ltd | Chemical compounds VII |
| JP4545437B2 (ja) | 2001-10-15 | 2010-09-15 | シェーリング コーポレイション | アデノシンａ２ａ受容体アンタゴニストとしてのイミダゾ（４，３−ｅ）−１，２，４−トリアゾロ（１，５−ｃ）ピリミジン |
| CA2468658C (en) * | 2001-11-30 | 2009-04-14 | Schering Corporation | [1,2,4]-triazole bicyclic adenosine a2a receptor antagonists |
| AU2002346503A1 (en) * | 2001-11-30 | 2003-06-17 | Schering Corporation | Adenosine A2a receptor antagonists |
| DE10159922A1 (de) | 2001-12-06 | 2003-06-26 | Gruenenthal Gmbh | Substituierte 2-Pyrrolidin-2-yl-1H-indol-Derivate |
| ES2716404T3 (es) * | 2002-01-28 | 2019-06-12 | Kyowa Hakko Kogyo Kk | Antagonistas de receptores A2A para su uso en el tratamiento de trastornos del movimiento |
| MXPA05006790A (es) * | 2002-12-19 | 2005-09-08 | Schering Corp | Usos de antagonistas del receptor adenosina a2a. |
| EP1633756B1 (de) * | 2003-04-09 | 2008-12-24 | Biogen Idec MA Inc. | A2a-adenosinrezeptorantagonisten |
| EP1622912B1 (de) | 2003-04-23 | 2009-05-27 | Schering Corporation | 2-alkinyl- und 2-alkenyl-pyrazolo-[4,3-e] -1,2,4-triazolo-[1,5-c] -pyrimidinadenosin a2a rezeptorantagonisten |
| DK1678182T3 (da) * | 2003-10-28 | 2007-06-04 | Schering Corp | Fremgangsmåde til fremstilling af substituerede 5-amino-pyrazolo[4,3-E]-1,2,4-triazolo-[1,5-C]pyrimidiner |
| ATE377599T1 (de) | 2003-12-01 | 2007-11-15 | Schering Corp | Verfahren zur herstellung von substituierten 5- aminopyrazolo(4,3-e)-1,2,4-triazolo(1,5- c)pyrimidinen |
| AR057817A1 (es) * | 2005-09-19 | 2007-12-19 | Schering Corp | Antagonistas del receptor a2a de 2-heteroaril-pirazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pirimidin adenosina. composiciones farmaceuticas |
-
2006
- 2006-06-07 JP JP2007520141A patent/JPWO2006132275A1/ja active Pending
- 2006-06-07 ES ES10005600T patent/ES2385702T3/es not_active Expired - Lifetime
- 2006-06-07 US US11/916,783 patent/US7851478B2/en active Active
- 2006-06-07 EP EP06757137A patent/EP1902716A4/de not_active Withdrawn
- 2006-06-07 EP EP10005600A patent/EP2258372B8/de not_active Expired - Lifetime
- 2006-06-07 AT AT10005600T patent/ATE556712T1/de active
- 2006-06-07 WO PCT/JP2006/311430 patent/WO2006132275A1/ja not_active Ceased
-
2012
- 2012-11-06 JP JP2012244147A patent/JP2013056911A/ja active Pending
-
2014
- 2014-08-27 JP JP2014172319A patent/JP2015007096A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013056911A (ja) | 2013-03-28 |
| US7851478B2 (en) | 2010-12-14 |
| EP2258372B8 (de) | 2012-12-19 |
| EP2258372B1 (de) | 2012-05-09 |
| EP1902716A1 (de) | 2008-03-26 |
| ES2385702T3 (es) | 2012-07-30 |
| JP2015007096A (ja) | 2015-01-15 |
| US20090105277A1 (en) | 2009-04-23 |
| JPWO2006132275A1 (ja) | 2009-01-08 |
| WO2006132275A1 (ja) | 2006-12-14 |
| EP1902716A4 (de) | 2009-05-13 |
| EP2258372A1 (de) | 2010-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2258372B8 (de) | A2A Antagonisten zur Behandlung von motorischen Störungen | |
| WO2005018557A3 (en) | Substituted pyridinones | |
| AP1822A (en) | Substituted pyridinones as modulators of P38 MAP kinase. | |
| PT1159279E (pt) | 4-oxo-4,7-di-hidrotieno¬2,3-b|piridino-5-carboxamidas como agentes antivirais | |
| MXPA05010621A (es) | Pirimidinonas sustituidas. | |
| NO20082136L (no) | 1,5-substituerte indol-2-yl-amidderivater | |
| IS8503A (is) | Azatvíhringja heteróhringir sem kannabínóníð-viðtakastillar | |
| EP1700856A4 (de) | Thiazolderivat | |
| TW200615266A (en) | Organic compounds | |
| WO2005095384A8 (en) | Pyrazine derivatives and pharmaceutical use thereof as adenosine antagonists | |
| DE602008004540D1 (de) | 2-oxo-2-(2-phenyl-5,6,7,8-tetrahydroindolizin-3-yl)acetamidderivate und verwandte verbindungen als antipilzmittel | |
| EA200400466A1 (ru) | Производные пиперазина с антагонистической активностью к рецептору ccr1 | |
| EP1757594A4 (de) | Chinazolinderivat | |
| ATE450514T1 (de) | Piperazinylalkylpyrazol-derivate zur verwendung als selektive calciumkanalblocker des t-typs und verfahren zu ihrer herstellung | |
| WO2005111002A3 (de) | Substituierte cycloalkylderivate zur behandlung von atemswegerkrankungen | |
| IL186777A0 (en) | (3,4-dihydro-quinazolin-2-yl) - (2-aryloxy-ethyl) - amines having an activity on the 5 - ht receptor | |
| ATE357917T1 (de) | Behandlung von dyskinesie durch mu-selektive opioidantagonisten | |
| CA2522813A1 (en) | 2-alkynyl-and 2-alkenyl-pyrazolo-¬4,3-e|-1,2,4-triazolo-¬1,5-c|-pyrimidine adenosine a2a receptor antagonists | |
| WO2004022540A3 (en) | Pyridazinone and pyridone derivatives as adenosine antagonists | |
| WO2008136377A1 (ja) | 二環式複素環化合物 | |
| MX2009004314A (es) | Diaril, dipiridinil y arilpiridinilderivados y usos de los mismos. | |
| WO2005090296A3 (en) | N-substituted benzene sulfonamides | |
| DK1725536T3 (da) | Imidazolin-derivater med CB1-antagonistisk aktivitet | |
| ATE325610T1 (de) | Xanthinderivative zur behandlung von hirnischämie | |
| ATE480527T1 (de) | Thiadiazolinderivate zur krebsbehandlung |